Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.96 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.96 |
| ▸ | NPC1 | O15118 | 1/20 | 0.96 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.96 |
| ▸ | HPGD | P15428 | 1/20 | 0.96 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.96 |
| ▸ | RAB9A | P51151 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | SCN1A | P35498 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.53 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL100360 | 1.00 | CYP2D6 (0.96) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| SCHEMBL239738 | 1.00 | CYP2D6 (0.96) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| SCHEMBL8136171 | 0.98 | CYP2D6 (0.93) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| SCHEMBL7446968 | 0.98 | CYP2D6 (0.93) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| Hydrochloric Acid SCHEMBL9277459 | 0.98 | CYP2D6 (1.00) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| Pipradrol SCHEMBL156360 | 0.95 | CYP2D6 (0.87) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| Pipradrol SCHEMBL4057811 | 0.93 | CYP2D6 (0.90) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| Sulfuric Acid SCHEMBL9452303 | 0.92 | CYP2D6 (0.82) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| SCHEMBL6295242 | 0.90 | CYP2D6 (0.79) | CYP2D6MAPK1KDM4ENPC1CYP1A2 | |
| SCHEMBL5054811 | 0.90 | CYP2D6 (0.79) | CYP2D6MAPK1KDM4ENPC1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3995492-B1 | A TWO-STEP PROCESS FOR PREPARING 3-SUBSTITUTED PHENYLALKYLAMINES | SpecGx LLC (US) | 2024-05-29 | — | — | EP | claimed |
| EP-3995492-A1 | A TWO-STEP PROCESS FOR PREPARING 3-SUBSTITUTED PHENYLALKYLAMINES | SpecGx LLC (US) | 2022-05-11 | — | — | EP | claimed |
| EP-3344602-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2018-07-11 | — | — | EP | claimed |
| US-20170267706-A1 | METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE | STRAITMARK HOLDING AG (CH) | 2017-09-21 | — | — | US | claimed |
| EP-3183258-A1 | METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE | Straitmark Holding AG (CH) | 2017-06-28 | — | — | EP | claimed |
| WO-2017037662-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE | Piramal Enterprises Limited (IN) | 2017-03-09 | — | — | WO | claimed |
| WO-2016026871-A1 | METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE | STRAITMARK HOLDING AG (CH) | 2016-02-25 | — | — | WO | claimed |
| US-20140323727-A1 | NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES | ACTAVIS GROUP PTC EHF (IS) | 2014-10-30 | — | — | US | claimed |
| US-20130150577-A1 | NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES | ACTAVIS GROUP PTC EHF (IS) | 2013-06-13 | — | — | US | claimed |
| EP-2398774-A2 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | Incyte Corporation (US) | 2011-12-28 | — | — | EP | claimed |
| EP-1147099-A1 | EPOXIDATION PROCESS USING AMINE CATALYSTS | The University of Sheffield (GB) | 2001-10-24 | — | — | EP | claimed |
| WO-2000044735-A1 | EPOXIDATION PROCESS USING AMINE CATALYSTS | THE UNIVERSITY OF SHEFFIELD (GB) | 2000-08-03 | — | — | WO | claimed |
| EP-0873298-A4 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMA INC (US) | 2000-05-17 | — | — | EP | claimed |
| US-5925666-A | DOPAMINE UPTAKE INHIBITORS; DRUG ABUSE AND DEPENDENCE, EATING DISORDERS, ATTENTION DEFICIT DISORDER, TOURETTE*S SYNDROME, GAMBLING | GUILFORD PHARMACEUTICALS INC. (US) | 1999-07-20 | — | — | US | claimed |
| EP-0794957-B1 | METHOD OF PRODUCING OPTICALLY ACTIVE METALLOCENYL PHOSPHINES | LONZA AG (CH) | 1999-04-21 | — | — | EP | claimed |
| WO-1999003467-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING COMPULSIVE DISORDERS USING PYRROLIDINE DERIVATIVES | GUILFORD PHARMACEUTICALS INC. (US) | 1999-01-28 | — | — | WO | claimed |
| EP-0873298-A1 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMACEUTICALS, INC. (US) | 1998-10-28 | — | — | EP | claimed |
| WO-1998007653-A1 | CHIRAL HYDRIDE COMPLEXES | ZEELAND CHEMICALS, INC. (US) | 1998-02-26 | — | — | WO | claimed |
| WO-1997024030-A1 | PYRROLIDINE DERIVATIVES | GUILFORD PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | claimed |
| WO-1997011934-A1 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMACEUTICALS, INC. (US) | 1997-04-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267706-A1 | METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE | PNPO, OXSR1, PPOX | CYP2D6 947/4885MAPK1 1540/4885KDM4E 2435/4885 |
| US-20140323727-A1 | NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES | THPO, P2RY4, TPMT | CYP2D6 180/4885MAPK1 802/4885KDM4E 1441/4885 |
| US-20130150577-A1 | NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES | THPO, P2RY4, TPMT | CYP2D6 180/4885MAPK1 802/4885KDM4E 1441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.